Ever Source Wealth Advisors, LLC Atara Biotherapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 35 shares of ATRA stock, worth $373. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 35
-0.0%
Holding current value
$373
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATRA
# of Institutions
7Shares Held
2.89MCall Options Held
0Put Options Held
0-
Kpcb Xv Associates, LLC1.88MShares$20 Million19.79% of portfolio
-
Antipodean Advisors LLC New York, NY1MShares$10.7 Million8.12% of portfolio
-
Ifp Advisors, Inc4.5KShares$48,0600.0% of portfolio
-
American Portfolios Advisors Holbrook, NY4.5KShares$48,0600.0% of portfolio
-
Wipfli Financial Advisors Llc,3.08KShares$32,8830.0% of portfolio
About Atara Biotherapeutics, Inc.
- Ticker ATRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,362,304
- Market Cap $1.01B
- Description
- Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...